Isolation and characteristics of dendritic cell progenitors from the bone marrow of the Hodgkin's disease patients.
Markowicz
S
S
M. Sklodowska-Curie Memorial Cancer Center, Warsaw, Poland.
Walewski
J
J
Kawecki
A
A
D000293:Adolescent; D000328:Adult; D001853:Bone Marrow / Q000187:drug effects / Q000276:immunology / Q000473:pathology*; D002454:Cell Differentiation / Q000187:drug effects; D002455:Cell Division / Q000187:drug effects; D003114:Colony-Forming Units Assay; D003713:Dendritic Cells / Q000187:drug effects / Q000276:immunology / Q000473:pathology*; D005260:Female; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000494:pharmacology; D006683:HLA-DQ Antigens / Q000378:metabolism; D006684:HLA-DR Antigens / Q000378:metabolism; D006412:Hematopoietic Stem Cells / Q000187:drug effects / Q000276:immunology / Q000473:pathology*; D006689:Hodgkin Disease / Q000209:etiology / Q000276:immunology / Q000473:pathology*; D006801:Humans; D066298:In Vitro Techniques; D008297:Male; D008875:Middle Aged; D011994:Recombinant Proteins / Q000494:pharmacology; D014409:Tumor Necrosis Factor-alpha / Q000494:pharmacology
D006683:HLA-DQ Antigens; D006684:HLA-DR Antigens; D011994:Recombinant Proteins; D014409:Tumor Necrosis Factor-alpha; D016178:Granulocyte-Macrophage Colony-Stimulating Factor